Brief: Karolinska Development's Svenska Vaccinfabriken Presents Scientific Advancements At International Conference

Kdventures AB

27/06/2022 15:47

June 27 (Reuters) - Karolinska Development AB  KDEV.ST :
    * KAROLINSKA DEVELOPMENT’S PORTFOLIO COMPANY SVENSKA
VACCINFABRIKEN PRESENTS SCIENTIFIC ADVANCEMENTS AT INTERNATIONAL
CONFERENCE
    * RESULTS FROM A PRECLINICAL STUDY INDICATING THAT COMPANY'S
CANDIDATE THERAPEUTIC VACCINE SVF-001 HAS POTENTIAL TO ELICIT AN
IMMUNE RESPONSE IN A DISEASE MODEL OF CHRONIC HEPATITIS B.

Source text for Eikon:  ID:nGNEbMb5Nz 
Further company coverage:  KDEV.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))